CIM INVESTMENT MANAGEMENT INC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 363 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.

Quarter-by-quarter ownership
CIM INVESTMENT MANAGEMENT INC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$222,000
-21.6%
1,435
-33.4%
0.07%
-25.0%
Q2 2021$283,000
+16.5%
2,155
-11.9%
0.09%
+11.4%
Q4 2020$243,000
+4.3%
2,4460.0%0.08%
-10.2%
Q3 2020$233,000
-13.7%
2,446
+1.5%
0.09%
-19.3%
Q2 2020$270,000
+29.2%
2,410
+20.5%
0.11%
+31.3%
Q4 2019$209,000
-41.1%
2,000
-43.9%
0.08%
-37.6%
Q3 2019$355,000
-12.8%
3,5650.0%0.13%
-10.7%
Q2 2019$407,000
-10.9%
3,565
-1.9%
0.15%
-15.3%
Q1 2019$457,000
+58.1%
3,635
+70.9%
0.18%
+40.8%
Q4 2018$289,000
-18.4%
2,127
-18.2%
0.12%
-3.1%
Q3 2017$354,000
-44.0%
2,599
-50.0%
0.13%
-42.4%
Q2 2017$632,000
+11.3%
5,203
-3.0%
0.22%
+14.9%
Q1 2017$568,000
+4.2%
5,3660.0%0.20%
-1.5%
Q4 2016$545,000
-0.5%
5,3660.0%0.20%
-5.3%
Q3 2016$548,000
-10.9%
5,366
+4.1%
0.21%
-18.0%
Q2 2016$615,000
+85.8%
5,156
+68.9%
0.26%
+67.8%
Q4 2015$331,000
+26.8%
3,0530.0%0.15%
+20.6%
Q3 2015$261,000
-3.7%
3,053
+13.6%
0.13%
+5.9%
Q2 2015$271,000
-34.7%
2,688
-50.0%
0.12%
-33.9%
Q1 2015$415,000
+45.1%
5,3790.0%0.18%
+37.4%
Q4 2014$286,000
+31.2%
5,379
+16.1%
0.13%
+18.0%
Q3 2014$218,0004,6350.11%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
KNOTT DAVID M 1,249,766$58,726,504,00011.17%
BVF INC/IL 1,108,763$52,101,00010.82%
GROW Partners, LLC 132,500$6,226,0005.58%
CARDINAL CAPITAL MANAGEMENT LLC /CT 936,825$44,021,0002.73%
First Light Asset Management, LLC 76,366$3,588,0002.45%
Healthcare Value Capital, LLC 50,000$2,350,0002.27%
OBERWEIS ASSET MANAGEMENT INC/ 168,337$7,910,0002.17%
RK Capital 174,283$8,190,0001.67%
Nichols Asset Management LLC 133,368$6,267,0001.30%
ASHFORD CAPITAL MANAGEMENT INC 108,289$5,089,0001.09%
View complete list of LIGAND PHARMACEUTICALS INC shareholders